CN108420937A - 一种治疗慢性湿疹中药配方及使用方法 - Google Patents
一种治疗慢性湿疹中药配方及使用方法 Download PDFInfo
- Publication number
- CN108420937A CN108420937A CN201810458150.5A CN201810458150A CN108420937A CN 108420937 A CN108420937 A CN 108420937A CN 201810458150 A CN201810458150 A CN 201810458150A CN 108420937 A CN108420937 A CN 108420937A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- chronic eczema
- medicine preparation
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims abstract description 9
- 238000011282 treatment Methods 0.000 claims abstract description 26
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 21
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 21
- 235000008434 ginseng Nutrition 0.000 claims abstract description 21
- 241000255789 Bombyx mori Species 0.000 claims abstract description 17
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 16
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 16
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 15
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 15
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241000601164 Clematis orientalis Species 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 8
- 241001521901 Tribulus lanuginosus Species 0.000 claims description 7
- 235000012054 meals Nutrition 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 241000208340 Araliaceae Species 0.000 claims 2
- 210000000952 spleen Anatomy 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 208000004880 Polyuria Diseases 0.000 abstract description 7
- 230000001939 inductive effect Effects 0.000 abstract description 6
- 230000035619 diuresis Effects 0.000 abstract description 5
- 208000008454 Hyperhidrosis Diseases 0.000 abstract description 4
- 208000013219 diaphoresis Diseases 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 231100000252 nontoxic Toxicity 0.000 abstract description 3
- 230000003000 nontoxic effect Effects 0.000 abstract description 3
- 238000013459 approach Methods 0.000 abstract description 2
- 239000002245 particle Substances 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 21
- 210000004369 blood Anatomy 0.000 description 21
- 240000005373 Panax quinquefolius Species 0.000 description 18
- 230000007812 deficiency Effects 0.000 description 17
- 208000003251 Pruritus Diseases 0.000 description 12
- 201000010099 disease Diseases 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 208000010668 atopic eczema Diseases 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 10
- 235000009508 confectionery Nutrition 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 230000003902 lesion Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 206010033733 Papule Diseases 0.000 description 6
- 230000001154 acute effect Effects 0.000 description 6
- 206010003549 asthenia Diseases 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 230000000306 recurrent effect Effects 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 206010000060 Abdominal distension Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010003591 Ataxia Diseases 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 206010010947 Coordination abnormal Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010013082 Discomfort Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102100040247 Tumor necrosis factor Human genes 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 210000000544 articulatio talocruralis Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 239000003018 immunosuppressive agent Substances 0.000 description 2
- 208000016290 incoordination Diseases 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241000590428 Panacea Species 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical group C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000031016 anaphase Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- -1 antibiotic Substances 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 1
- 229960002537 betamethasone Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 206010018388 glossodynia Diseases 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 208000018937 joint inflammation Diseases 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 208000011117 substance-related disease Diseases 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供了一种治疗慢性湿疹中药配方及使用方法。一种治疗慢性湿疹中药配方,其不同之处在于,所述配方由以下组分的重量份的原料配比而成:人参1‑4份、当归1‑6份、生地1‑6份、桂枝1‑4份、白芍1‑4份、白术1‑6份、葛根1‑6份、僵蚕1‑4份、忍冬藤1‑6份、知母1‑6份、连翘1‑6份以及威灵仙1‑6份。本发明的有益效果在于全方共奏实脾解表,并非一味的清热利湿,实脾实表与祛风利湿相兼顾,通络和营与清热养阴相兼顾,组方严谨,收效较好。从古籍经典创新治疗思想,具有无毒低副作用、价廉等特点,疗效显著、复发少,为慢性湿疹的治疗提供新思路与疗法,同时可制备成颗粒具有携带方便的特点。
Description
技术领域
本发明属于中药技术领域,具体涉及一种治疗慢性湿疹中药配方及使用方法。
背景技术
湿疹是由多种内外复杂因素所引起的一种具有明显渗出倾向的皮肤炎症反应。临床上以瘙痒显著,对称性分布,急性以丘疱疹为主,慢性常以苔藓样改变为主及反复发作、易成慢性为其特征。该病西医病因病机,目前尚不明确,多与免疫功能异常变态反应有关。有研究表明,组胺是诱发湿疹瘙痒的原因之一;另外炎性递质白介素、白三烯、肿瘤坏死因子(TNF)等也可能造成瘙痒。西医主要的系统治疗为抗组胺药、抗生素、维生素C、糖皮质激素、免疫抑制剂等治疗,但停药后容易复发,且激素类及免疫抑制剂副作用大。国内湿疹发病率非常高,占皮肤科门诊病例的15%-30%,严重影响病人的生活质量,造成心身损害。
慢性湿疹属于中医“浸淫疮”、“血风疮”等范畴,多因禀赋不耐,风、湿、热邪阻于肌肤所致,或因饮食失节,嗜酒或过食辛辣之品,伤及脾胃,致使湿热内蕴,复感外邪,两邪相搏,阻于腠理、浸淫肌肤而发病;或因素体虚弱,脾虚不运,湿邪留恋,肌肤失养发病;或因湿热蕴久,病久伤血,血虚生风生燥,肌肤失去濡养而成。现基于中医“伤寒论”、“络病学”等经典理论,认为慢性湿疹属“太阴兼太阳病变”,病变基础以“太阳经表虚风寒湿郁滞”、“太阳经表虚营卫不调”“太阴湿土运化失司”向“整体太阴脾虚、太阳表虚”“局部皮肤风湿郁热、络滞”发展,属本虚标实,现存的治疗慢性湿疹中药配方中大多一味的清热利湿,难以兼顾实脾实表与祛风利湿。
发明内容
为克服现有技术的缺陷,本发明提供了一种治疗慢性湿疹中药配方及使用方法。
具体技术方案如下:
一种治疗慢性湿疹中药配方,其不同之处在于,所述配方由以下组分的重量份的原料配比而成:人参1-4份、当归1-6份、生地1-6份、桂枝1-4份、白芍1-4份、白术1-6份、葛根1-6份、僵蚕1-4份、忍冬藤1-6份、知母1-6份、连翘1-6份以及威灵仙1-6份。
优选地,所述配方由以下组分的重量份的原料配比而成:人参2份、当归4份、生地6份、桂枝4份、白芍4份、白术4份、葛根6份、僵蚕2份、忍冬藤6份、知母6份、连翘4份以及威灵仙3份。
优选地:所述配方组分还包括1-6份重量份的白蒺藜。
上述一种治疗慢性湿疹中药配方的使用方法,其特征在于,所述配方以汤剂或制备成颗粒剂后饭前服用,每日3次,一周为一个疗程,治疗时间为1-4个疗程。
上述技术方案中,所述汤剂的制作方法为将中药原料清洗干净,一起放入锅中煎煮成汤药,武火煎煮烧开后,改用文火煎30分钟,倒出药汁,煎煮两次,将两次药汁混合。
人参:味甘、微苦,性温、平,入脾、肺经。《神农本草经》注:“人参,味甘微寒,主补五脏,安精神,定魂魄,止惊悸,除邪气,明目,开心益智。”《用药法象》:“人参能补肺中之气,肺气旺则四脏之气皆旺,肺主诸气故也。张仲景以人参为补血者,盖血不自生,须得阳气之药乃生,阳生阴长,血乃旺矣。”《薛氏医案》:“人参但入肺经,助肺气而通经活血,乃气中之血药也。”人参用为本方君药补五脏之气,生气流通以益真气,既能补先天虚弱,又能通经活血。
白术:味苦、甘,性温,归脾、胃经。主补气健脾,燥湿利水。现代药理研究表明白术可以调节身体免疫力、抗病原微生物、保肝利尿、降血糖、降血压等作用。白术与人参共为君药,补后天脾胃之气,实太阴脾气,以卫太阳表气。先天之气与后天之气互养,为慢性湿疹的治疗提供坚实的基盾,且白术能燥湿利水,慢性湿疹久病后期多气虚血水难行,易滋生痰湿,反复迁延不愈,白术不仅能实脾气,更能驱表邪。
当归:味甘、辛,性温,归肝、心、脾经。主补血活血,调经止痛。为补血圣药,既能补血又能行血。慢性湿疹后期多有血虚风燥,以当归为臣药达到补血祛风之效。后期效果尤胜。
白芍:味苦、酸,性微寒。归肝、脾经。主养血敛阴,柔肝止痛。与当归合为臣药增加养血护肝之效,柔肝养土、风木平则脾土生。
桂枝:味、辛、甘,性温,归肺、心、膀胱经。主发汗解表、散寒止痛、通阳化气。《本经疏证》:“桂枝能利关节,温经通脉,此其体也……盖其用之道有六:曰和营,曰通阳,曰利水,曰下气,曰行瘀,曰补中。”桂枝为佐,合白芍调和营卫为其一,合白术利水燥湿为其二,于太阳膀胱经外解表邪为其三,以补太阳表虚,驱邪补虚之效共达。
威灵仙:味辛、咸,性温,归膀胱经。主驱风湿、通经络之效。常用治疗风湿性关节炎,此处以威灵仙独主膀胱经,佐用引药入膀胱经,以实太阳膀胱经。
生地:味甘,性寒,归心、肝、肾经。主清热凉血、养阴生津。慢性湿疹病程多较长,久病多生瘀热,且局部气血常滞留与外邪交杂,更易生郁热,佐以生地清营血分之热,且合白芍清热不伤阴。
僵蚕:味咸、辛,性平,归肝、肺、胃经。主息风通络、化痰散结。《本草求真》:“僵蚕,祛风散寒,燥湿化痰,温行血脉之品。”临床常以虫类药通络效果尤佳,收效颇奇,此方以僵蚕收效尤佳,解决慢性湿疹局部“络滞”主要问题,促进局部络脉的血流通畅,使皮肤基层修复更快。
葛根:味甘、辛,性凉,归肺、胃经。主解肌退热,透疹,生津止渴。清解局部肌肉郁热,为使药,达清解气分热,解除局部郁热。
忍冬藤:味甘,性寒,归肺、胃经。主祛风通络,清热解毒。为使药,辅以僵蚕通络而解除“络滞郁热”。
知母:味苦,性寒,归肺、胃、肾经。主滋阴降火,清热润燥。为使药,性清润。
连翘:味苦,性凉,归心、肝、胆经。主清热解毒,散结消肿。为使药,合知母清润解表,合葛根透营血分热。
白蒺藜:味苦,性凉,归肝经。主祛风止痒、消炎止痛。
本发明的有益效果:本方基于中医“伤寒论”、“络病学”等经典理论,提出慢性湿疹属“太阴兼太阳病变”,病变基础以“太阳经表虚风寒湿郁滞”、“太阳经表虚营卫不调”“太阴湿土运化失司”向“整体太阴脾虚、太阳表虚”“局部皮肤风湿郁热、络滞”发展,属本虚标实的新思想,方中以人参、白术补脾益气,当归、白芍养血活血,合桂枝、威灵仙祛风除湿、调和营卫,生地清营分热养阴润燥,合葛根清气分热解郁热,僵蚕、忍冬藤通络化痰清热,知母、连翘清润解表,全方共奏实脾解表,并非一味的清热利湿,实脾实表与祛风利湿相兼顾,通络和营与清热养阴相兼顾,组方严谨,收效较好。从古籍经典创新治疗思想,具有无毒低副作用、价廉等特点,疗效显著、复发少,为慢性湿疹的治疗提供新思路与疗法,同时可制备成颗粒具有携带方便的特点。
具体实施方式:
下面结合具体实施例进一步说明本发明技术方案:
实施例1:
一种慢性湿疹中药配方,选用中药原料按重量配比可以为:人参2份(每份5克)、当归4份、生地6份、桂枝4份、白芍4份、白术4份、葛根6份、僵蚕2份、忍冬藤6份、知母6份、连翘4份、威灵仙3份。
将上述中药原料清洗干净,一起放入锅中煎煮成汤药,武火煎煮烧开后,改用文火煎30分钟,倒出药汁,煎煮两次,将两次药汁混合,每日3次,饭前服用。
实施例2:
一种慢性湿疹中药配方,选用中药原料按重量配比可以为:人参2份(每份5克)、当归4份、生地6份、桂枝4份、白芍4份、白术4份、葛根6份、僵蚕2份、忍冬藤6份、知母6份、连翘4份、威灵仙3份、白蒺藜4份。
皮肤瘙痒明显加入了白蒺藜4份,将上述中药原料清洗干净,一起放入锅中煎煮成汤药,武火煎煮烧开后,改用文火煎30分钟,倒出药汁,煎煮两次,将两次药汁混合,每日3次,饭前服用。
实施例3
一种慢性湿疹中药配方,选用中药原料按重量配比可以为:人参2份(每份5克)、当归4份、生地6份、桂枝4份、白芍4份、白术4份、葛根6份、僵蚕2份、忍冬藤6份、知母6份、连翘4份、威灵仙3份,各个中药依据现代科技提取方法采取全成分颗粒剂。
实施例4:
一种慢性湿疹中药配方,选用中药原料按重量配比可以为:人参2份(每份5克)、当归4份、生地6份、桂枝4份、白芍4份、白术4份、葛根6份、僵蚕2份、忍冬藤6份、知母6份、连翘4份、威灵仙3份。
将上述中药原料清洗干净,一起放入锅中煎煮成汤药,武火煎煮烧开后,改用文火煎30分钟,倒出药汁,煎煮两次,将两次药汁混合,每日3次,饭前服用,一周为一个疗程,一般治疗1-4个疗程。煎煮两次后再次加入水,煎煮1小时,待药汁温热时局部外敷用,用来局促进局部皮肤血液循环及物质代谢,每日3次,配合内服用,一周为一个疗程,一般治疗1-4个疗程。
病例一
某女,40岁,既往诊断为湿疹,曾用多种药物治疗效果欠佳,激素外用治疗可缓解症状,但仍反复发作,近2年服用钙泊三醇倍他米松控制症状,效果欠佳,常规中药治疗3年未见明显效果,于2016年8月13日首诊,主诉:双手指红肿、干燥、皲裂伴有脱屑反复发作8年,加重3年,发作时瘙痒剧烈不能忍受,舌质嫩红,苔薄黄,脉细促;诊断:慢性湿疹(浸淫疮),血瘀风燥证。处方如下人参10g、当归30g、生地20g、桂枝20g、白芍20g、白术20g、葛根15g、僵蚕20g、忍冬藤30g、知母20g、连翘15g、威灵仙15g等为主方5剂治疗,内服同时配合外敷外用,并嘱患者将激素逐步减量,复诊时,瘙痒、红肿较前缓解,再守上方4剂巩固治疗,上述症状基本控制,未再用激素。
病例二
某男,25岁,平素体健,无其他特殊病史。2017年4月5日首诊,诉双下肢皮肤紫暗潮红、丘疹伴有水疱反复发作一月余。患者膝关节以下及踝关节以上皮肤出现明显紫暗潮红、丘疹伴有水疱,抓破渗液流脂水,且局部皮肤灼热瘙痒,大便粘滞不爽、不成形,每天1-2次,饮食、睡眠、小便可。舌质红,苔黄稍腻,脉滑稍弦。诊断:慢性湿疹(浸淫疮),湿热蕴肤证。处方如下人参10g、当归20g、生地25g、桂枝15g、白芍20g、白术25g、葛根20g、僵蚕10g、忍冬藤30g、知母20g、连翘20g、威灵仙10g、白蒺藜15g等为主方5剂治疗,复诊时诉瘙痒灼热较前明显减轻,双下肢皮肤潮红、丘疹较前好转,未见明显水疱,大便尚可,余未诉其他特殊不适,再守前方5剂继续治疗,再次复诊时,皮肤未见明显潮红,丘疹已消退,无明显灼热瘙痒,再予5剂巩固疗效。
病例三
某女,46岁,平素健康状况一般,既往无特殊病史。2017年9月15日首诊,诉双下肢瘙痒伴有丘疹反复发作半年余。近半年来患者双下肢膝关节以下踝关节以上反复出现皮肤瘙痒伴有丘疹,且局部皮肤潮红,少许皮损部位有鳞屑,伴有嗳气、纳少、腹胀便溏,大便1天1次、不成形,舌质淡嫩,苔白,脉细稍濡。诊断:慢性湿疹(浸淫疮),脾虚湿蕴证。处方如下人参15g、当归20g、生地20g、桂枝15g、白芍20g、白术30g、葛根15g、僵蚕10g、忍冬藤20g、知母15g、连翘15g、威灵仙10g、白蒺藜20g等为主方5剂治疗,复诊时诉瘙痒较前明显缓解,腹胀减轻,饮食较前增多,无嗳气等不适,再守前方5剂巩固治疗,瘙痒、丘疹等症状基本控制。
治疗时注意事项:
1、勿饮冷水凉食,宜饮温热水,病变部位勿接触凉水,寒性凝滞,对于局部血液循环不利,饮温热水以促进局部循环。
2、勿食腌制品,多食新鲜鱼肉,避免腌制品诱发局部皮肤过敏,增加炎症反应。
3、食萝卜与药物间隔1小时以上,因方中含有人参。
本中药配方用于治疗慢性湿疹,基于中医“伤寒论”、“络病学”等经典理论,提出慢性湿疹属“太阴兼太阳病变”,病变基础以“太阳经表虚风寒湿郁滞”、“太阳经表虚营卫不调”“太阴湿土运化失司”向“整体太阴脾虚、太阳表虚”“局部皮肤风湿郁热、络滞”发展,属本虚标实的新理论,认为治疗切不可一味的清热利湿,宜实脾实表与祛风利湿相兼顾,通络和营与清热养阴相兼顾,此新治疗思路组方严谨,从根本上治疗慢性湿疹,比西医的对症治疗收效较好,且复发少,无药物依赖性,无毒低副作用,且价格廉价,使用方便。
以上所述仅为本发明的实施例,并非因此限制本发明的专利范围,凡是利用本发明说明书内容所作变换,或直接或间接运用在其他相关的技术领域,均同理包括在本发明的专利保护范围内。
Claims (5)
1.一种治疗慢性湿疹中药配方,其特征在于,所述配方由以下组分的重量份的原料配比而成:人参1-4份、当归1-6份、生地1-6份、桂枝1-4份、白芍1-4份、白术1-6份、葛根1-6份、僵蚕1-4份、忍冬藤1-6份、知母1-6份、连翘1-6份以及威灵仙1-6份。
2.根据权利要求1所述一种治疗慢性湿疹中药配方,其特征在于,所述配方由以下组分的重量份的原料配比而成:人参2份、当归4份、生地6份、桂枝4份、白芍4份、白术4份、葛根6份、僵蚕2份、忍冬藤6份、知母6份、连翘4份以及威灵仙3份。
3.根据权利要求1所述一种治疗慢性湿疹中药配方,其特征在于:所述配方组分还包括1-6份重量份的白蒺藜。
4.权利要求1~3任一项所述一种治疗慢性湿疹中药配方的使用方法,其特征在于,所述配方以汤剂或制备成颗粒剂后饭前服用,每日3次,一周为一个疗程,治疗时间为1-4个疗程。
5.根据权利要求4所述一种治疗慢性湿疹中药配方的使用方法,其特征在于,所述汤剂的制作方法为将中药原料清洗干净,一起放入锅中煎煮成汤药,武火煎煮烧开后,改用文火煎30分钟,倒出药汁,煎煮两次,将两次药汁混合。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810458150.5A CN108420937A (zh) | 2018-05-14 | 2018-05-14 | 一种治疗慢性湿疹中药配方及使用方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810458150.5A CN108420937A (zh) | 2018-05-14 | 2018-05-14 | 一种治疗慢性湿疹中药配方及使用方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108420937A true CN108420937A (zh) | 2018-08-21 |
Family
ID=63163029
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810458150.5A Pending CN108420937A (zh) | 2018-05-14 | 2018-05-14 | 一种治疗慢性湿疹中药配方及使用方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108420937A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109846777A (zh) * | 2019-02-01 | 2019-06-07 | 上海珈凯生物科技有限公司 | 一种具有缓解婴童湿疹功效的植物提取物组合物及其制备方法、应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104398915A (zh) * | 2014-12-07 | 2015-03-11 | 唐云峰 | 一种用于慢性湿疹的中药组合物 |
-
2018
- 2018-05-14 CN CN201810458150.5A patent/CN108420937A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104398915A (zh) * | 2014-12-07 | 2015-03-11 | 唐云峰 | 一种用于慢性湿疹的中药组合物 |
Non-Patent Citations (2)
Title |
---|
李元文: "《当代皮肤科临床家丛书》", 31 January 2017, 中国医药科技出版社 * |
谢文平: "中医药治疗慢性湿疹的研究进展 ", 《广州中医药大学学报》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109846777A (zh) * | 2019-02-01 | 2019-06-07 | 上海珈凯生物科技有限公司 | 一种具有缓解婴童湿疹功效的植物提取物组合物及其制备方法、应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101455738B (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN101496887B (zh) | 治疗急性热重痒重、湿重症型和慢性荨麻疹的药物 | |
CN103736069B (zh) | 一种治疗风湿病的膏药及其制备方法 | |
CN102362974A (zh) | 一种治疗荨麻疹的中药组合物 | |
CN102895610A (zh) | 一种治疗水肿的药物 | |
CN108420937A (zh) | 一种治疗慢性湿疹中药配方及使用方法 | |
CN102512647B (zh) | 一种治疗虚寒性腹痛的中药组合物 | |
CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
CN102940723A (zh) | 一种治疗气虚型经期延长的中药组合物 | |
CN104771585A (zh) | 一种治疗急性肾炎的中药组合物及制备方法 | |
CN104257986A (zh) | 一种治疗肾炎的中药 | |
CN104825892B (zh) | 一种治疗排卵期出血的中药制剂及其制备方法 | |
CN104606395A (zh) | 一种治疗经行发热的中药方剂 | |
CN104116983A (zh) | 一种预防月子病的口服液 | |
CN104740405B (zh) | 一种治疗过敏性紫癜性肾损害的中药制剂及制备方法 | |
CN103623361A (zh) | 用于治疗脑血栓的中药组合物 | |
CN104013728B (zh) | 一种综合治疗带状疱疹的中药制剂及其制备方法 | |
CN101987136B (zh) | 一种治疗神经性皮炎的药物及其制备方法 | |
CN105535581B (zh) | 一种治疗夏季皮炎的药物 | |
CN104784649A (zh) | 一种治疗肩关节周围炎的中药汤剂 | |
CN104888182A (zh) | 一种治疗产后腹痛的中药制剂及其制备方法 | |
CN104958705A (zh) | 一种治疗口腔溃疡的中药 | |
CN104689205A (zh) | 一种治疗失眠多梦的中药制剂及制备方法 | |
CN104645247A (zh) | 一种治疗肝豆状核变性的中药制剂及其制备方法 | |
CN104042993A (zh) | 缓解产后便秘的中药膏剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180821 |